Institutional investors hold a majority ownership of AMGN through the 83.04% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2013, these large investors purchased a net $4.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEUTSCHE BANK INVESTMENT MANAGEM... Bought 1.7 Million shares of Amgen Inc
ADAGE CAPITAL MANAGEMENT LP Bought 1.6 Million shares of Amgen Inc
BMO ASSET MANAGEMENT, INC. Bought 1.6 Million shares of Amgen Inc